Analysis of prepulse inhibition in mouse lines overexpressing 22q11.2 orthologues.

Animal models have been useful in elucidating the genetic basis of the cognitive and behavioural phenotypes associated with the 22q11.2 microdeletions. Loss-of-function models have implicated a number of genes as playing a role in prepulse inhibition (PPI) of the startle response. Here, we report the generation and initial analysis of bacterial artificial chromosome (BAC) transgenic (Tg) mice, overexpressing genes from within the 22q11.2 locus. We used engineered BAC constructs to generate Tg lines and quantitative RT-PCR to assess levels of gene expression in each line. We assessed PPI and open-field activity in mice from two low copy number lines. In Tg-1, a line overexpressing Prodh and Vpreb2, PPI was significantly increased at prepulse levels of 78 dB and 82 dB while no differences were found in activity measures. By contrast, no significant differences were found in PPI testing of the Tg-2 line overexpressing Zdhhc8, Ranbp1, Htf9c, T10, Arvcf and Comt. Taken together with previous loss-of-function reports, these findings suggest that Prodh has a key role in modulating the degree of sensorimotor gating in mice and possibly in humans and provide additional support for an important role of this pathway in modulating behavioural deficits associated with genomic gains or losses at 22q11.2.

[1]  Joseph A. Gogos,et al.  Palmitoylation-dependent neurodevelopmental deficits in a mouse model of the 22q11 microdeletion , 2008, Nature Neuroscience.

[2]  Paul Pavlidis,et al.  Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model , 2008, Nature Genetics.

[3]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[4]  A. Minassian,et al.  Sensorimotor Gating Deficits in Adults with Autism , 2007, Biological Psychiatry.

[5]  A. Alberti,et al.  1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features , 2007, Clinical genetics.

[6]  N. Motavalli Mukaddes,et al.  Autistic disorder and 22q11.2 duplication , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[7]  A. Laquérriere,et al.  The intrafamilial variability of the 22q11.2 microduplication encompasses a spectrum from minor cognitive deficits to severe congenital anomalies , 2006, American journal of medical genetics. Part A.

[8]  M. Owen,et al.  Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Kucherlapati,et al.  A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jie Qin,et al.  Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice , 2005, Nature Neuroscience.

[11]  Stephan Eliez,et al.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome , 2005, Nature Neuroscience.

[12]  M. Karayiorgou,et al.  Lower prepulse inhibition in children with the 22q11 deletion syndrome. , 2005, The American journal of psychiatry.

[13]  L. Shaffer,et al.  Microduplication and triplication of 22q11.2: a highly variable syndrome. , 2005, American journal of human genetics.

[14]  Maria Karayiorgou,et al.  Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia , 2004, Nature Genetics.

[15]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Heintz,et al.  Bac to the future: The use of bac transgenic mice for neuroscience research , 2001, Nature Reviews Neuroscience.

[17]  Joe C. Adams,et al.  Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects. , 2001, Human molecular genetics.

[18]  P. Scambler,et al.  Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. , 1999, Human molecular genetics.

[19]  M. Karayiorgou,et al.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice , 1999, Nature Genetics.

[20]  V. Pickel,et al.  The Mammalian Brain High-Affinity l-Proline Transporter Is Enriched Preferentially in Synaptic Vesicles in a Subpopulation of Excitatory Nerve Terminals in Rat Forebrain , 1999, The Journal of Neuroscience.

[21]  I. Mårtensson,et al.  The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co‐expressed during B cell development , 1996, European journal of immunology.

[22]  T. van Amelsvoort,et al.  Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. , 2007, Human molecular genetics.